Posters
Presentation Type
Poster
Discipline Track
Community/Public Health
Abstract Type
Research/Clinical
Abstract
Background: The COVID-19 pandemic has impacted public health in Mexico. As of February 2020, there have been at least four "waves" of contagion that resulted in 5.82 million positive cases and more than 325 thousand deaths. At the beginning of the COVID-19 pandemic, hospital and population-based information was available, frequently with non-specific symptoms. Little was known about the risk factors for mortality in specific conditions. We described the clinical characteristics of patients with COVID-19 in Reynosa, Tamaulipas during 2020 and identified the risk factors for mortality.
Methods: The COVID-19 cases registered from March to November 2020 in Reynosa were divided into survivors and non-survivors. The study had a retrospective cohort design. Data was obtained from the platform of the Respiratory Disease Surveillance System (SISVER), belonging to the National Epidemiological Surveillance System (SINAVE) of the Mexican Ministry of Health (https://sinave.gob.mx/). The variables considered were the age and gender of each patient. Twenty-five symptoms were included (fever, cough, headache, myalgia, arthralgia, among others); the outcome variable was the detection of COVID-19. Associated comorbidities were diabetes, obesity, hypertension, among others. The outcome variable was mortality. Data were analyzed using χ2 tests, Mann-Whitney tests, principal component analysis, and the Cox regression model.
Results:The highest number of COVID-19 cases and deaths was observed in July, in men between 36-40 years old. The most frequent symptoms (37-51%) were headache, fever, cough, myalgia, and arthralgia. Clinical characteristics between survivors and non-survivors were significant (P
Conclusions: The most frequent symptoms in positive COVID-19 patients in Reynosa during 2020 were headache, fever, cough, myalgia, and arthralgia. Age, gender and diabetes, hypertension, heart disease, COPD, and CKD increase mortality. The factors with the highest risk of death were age over 80 years, admitted to the ICU or intubated.
Recommended Citation
Vargas Garcia, Luis G.; Díaz Cisneros, Francisco E.; Gutiérrez Sierra, Antonio; Rosales Martínez, Juan; Lara Duck, Manlio F.; and Mayek Pérez, Netzahualcoyotl, "Clinical Characteristics and Risk Factors For Mortality During the 'First Wave' of COVID-19 In Reynosa, Tamaulipas" (2023). Research Symposium. 65.
https://scholarworks.utrgv.edu/somrs/2022/posters/65
Included in
Clinical Epidemiology Commons, Community Health and Preventive Medicine Commons, Epidemiology Commons, Family Medicine Commons, Immune System Diseases Commons, Respiratory Tract Diseases Commons, Virus Diseases Commons
Clinical Characteristics and Risk Factors For Mortality During the 'First Wave' of COVID-19 In Reynosa, Tamaulipas
Background: The COVID-19 pandemic has impacted public health in Mexico. As of February 2020, there have been at least four "waves" of contagion that resulted in 5.82 million positive cases and more than 325 thousand deaths. At the beginning of the COVID-19 pandemic, hospital and population-based information was available, frequently with non-specific symptoms. Little was known about the risk factors for mortality in specific conditions. We described the clinical characteristics of patients with COVID-19 in Reynosa, Tamaulipas during 2020 and identified the risk factors for mortality.
Methods: The COVID-19 cases registered from March to November 2020 in Reynosa were divided into survivors and non-survivors. The study had a retrospective cohort design. Data was obtained from the platform of the Respiratory Disease Surveillance System (SISVER), belonging to the National Epidemiological Surveillance System (SINAVE) of the Mexican Ministry of Health (https://sinave.gob.mx/). The variables considered were the age and gender of each patient. Twenty-five symptoms were included (fever, cough, headache, myalgia, arthralgia, among others); the outcome variable was the detection of COVID-19. Associated comorbidities were diabetes, obesity, hypertension, among others. The outcome variable was mortality. Data were analyzed using χ2 tests, Mann-Whitney tests, principal component analysis, and the Cox regression model.
Results:The highest number of COVID-19 cases and deaths was observed in July, in men between 36-40 years old. The most frequent symptoms (37-51%) were headache, fever, cough, myalgia, and arthralgia. Clinical characteristics between survivors and non-survivors were significant (P
Conclusions: The most frequent symptoms in positive COVID-19 patients in Reynosa during 2020 were headache, fever, cough, myalgia, and arthralgia. Age, gender and diabetes, hypertension, heart disease, COPD, and CKD increase mortality. The factors with the highest risk of death were age over 80 years, admitted to the ICU or intubated.